Frier, E. M., Lahti-Pulkkinen, M., Lin, C., Decrue, F., Zoega, H., Allegaert, K., Been, J., Burgner, D., Duhig, K., Einarsdóttir, K., Florian, L., Fraser, A., Gissler, M., Gyamfi-Bannerman, C., Pedersen, L. H., Miller, J., Mol, B., Murray, S. R., Norman, J. ... the Co-OPT Collaboration (2025). Associations of Antenatal Corticosteroids With Neurodevelopment in Children Aged 27–30 Months: A Population-Based Cohort Study. BJOG: An International Journal of Obstetrics and Gynaecology. Advance online publication. https://doi.org/10.1111/1471-0528.18101

Hansen, A. L., Christiansen, C. F., Brøns, C., Engelhard, L. M., Hansen, T., Nielsen, J. S., Vestergaard, P., Højlund, K., Jessen, N., Olsen, M. H., Sørensen, H. T., Rossing, P., Thomsen, R. W. & Vaag, A. (2025). Birthweight and risk of chronic kidney disease after a type 2 diabetes diagnosis in the DD2 cohort. Diabetologia. Advance online publication. https://doi.org/10.1007/s00125-024-06357-4

Hjelholt, A. J., Bach, F. W., Kasch, H., Støvring, H., Jensen, T. S. & Jørgensen, J. O. L. (2025). Cabergoline as a preventive migraine treatment: A randomized clinical pilot trial. PLOS ONE, 20(4 April), Artikel e0320937. https://doi.org/10.1371/journal.pone.0320937

Kornerup, L. S., Kraglund, F., Askgaard, G., Vilstrup, H. & Jepsen, P. (2025). Cirrhosis epidemiology in Denmark 1998–2022, and 2030 forecast. JHEP Reports, 7(5), Artikel 101353. https://doi.org/10.1016/j.jhepr.2025.101353

Watson, H., Jepsen, P., Vilstrup, H. & Krarup, H. (2025). Delta in Denmark: prevalence of hepatitis delta virus infection. Infectious Diseases, 57(2), 202-206. https://doi.org/10.1080/23744235.2024.2434887

Kristensen, F. P. B., Domazet, S. L., Nielsen, J. S., Stidsen, J. V., Højlund, K., Beck-Nielsen, H., Vestergaard, P., Jessen, N., Olsen, M. H., Hansen, T., Brøns, C., Vaag, A., Sørensen, H. T. & Thomsen, R. W. (2025). Elevated risk of infection in individuals with hyperinsulinaemic type 2 diabetes: a Danish 12 year cohort study. Diabetologia, 68(3), 576-587. https://doi.org/10.1007/s00125-024-06342-x

Kriikku, P., Edvardsen, H. M. E., Thelander, G., Thordardottir, S., Andersen, C. U., Ojanperä, I., Jönsson, A. K., Frost, J., Hermansen, S. K., Delaveris, G. J. M. & Simonsen, K. W. (2025). Fatal poisonings in Nordic countries in 2022 among people who use drugs. Forensic Science International: Reports, 11, Artikel 100408. https://doi.org/10.1016/j.fsir.2025.100408

Hansen, A. L., Andersen, M. K., Engelhard, L. M., Brøns, C., Hansen, T., Nielsen, J. S., Vestergaard, P., Højlund, K., Jessen, N., Olsen, M. H., Thomsen, R. W. & Vaag, A. (2025). Impact of TCF7L2 rs7903146 on clinical presentation and risk of complications in patients with type 2 diabetes. Diabetes, Obesity and Metabolism, 27(4), 2002-2011. https://doi.org/10.1111/dom.16193

Thunbo, M. Ø., Vendelbo, J. H., Larsen, A., Witte, D. R. & Pedersen, L. H. (2025). Maternal Demographic Patterns in Medication use During Pregnancy: A Nationwide Register Study. Basic & Clinical Pharmacology & Toxicology, 136(4), Artikel e70020. https://doi.org/10.1111/bcpt.70020

Bangshaab, M., Svart, M. V., Rittig, N., Pedersen, M. G. B., Voigt, J., Jessen, N. & Møller, N. (2025). Metabolic effects of 3-hydroxybutyrate infusion in individuals with type 1 diabetes compared with healthy control participants: a randomised crossover trial showing intact feedback suppression of lipolysis. Diabetologia. Advance online publication. https://doi.org/10.1007/s00125-025-06423-5

Ostenfeld, A., Lyngholm, S., Christensen, S. E., Petersen, T. S., Andersen, J. T., Westergaard, H. B., Pedersen, L. H. & Løkkegaard, E. C. L. (2025). Mirtazapine in pregnancy and lactation: A systematic review of adverse outcomes. Acta Psychiatrica Scandinavica, 151(1), 6-32. https://doi.org/10.1111/acps.13749

Sønderskov, M. B., Khatir, D. S., Kjærgaard, K. D., Hasselstrøm, J. B., Sørensen, L. K., Sædder, E. A. & Andersen, C. U. (2025). Pharmacokinetics and Side Effects of Δ⁹-Tetrahydrocannabinol and Cannabidiol in Patients with Different Stages of CKD. Kidney International Reports, 10(3), 707-719. https://doi.org/10.1016/j.ekir.2024.12.030

Kolding, L., Henriksen, JN., Sædder, EA., Ovesen, PG. & Pedersen, LH. (2025). Pregnancy Outcomes After Semaglutide Exposure. Basic and Clinical Pharmacology and Toxicology, 136(4), Artikel e70021. https://doi.org/10.1111/bcpt.70021

Nielsen, S. Y., Hoffmann-Lücke, E., Henriksen, T. B., Hartvigsen, C. M., Helmig, R. B., Khalil, M. R., Møller, J. K., Pedersen, L. H., Murra, M. & Greibe, E. (2025). Timing and dosage of intrapartum prophylactic penicillin for preventing early-onset group B streptococcal disease: Assessing maternal and umbilical cord blood concentration. Archives of Disease in Childhood: Fetal and Neonatal Edition, 110(2), F128-F132. Artikel fetalneonatal-2024-326986. https://doi.org/10.1136/archdischild-2024-326986

Vogel, I., Andreasen, L., Balslev-Harder, M., Becher, N., Ernst, A., Gadsbøll, K., Hjortshøj, T. D., Hvidbjerg, M. S., Larsen, M., Lou, S., Bay Lund, I. C., Pedersen, L. H., Sønderberg Roos, L. K., Sperling, L., Sunde, L., Tørring, P. M., Vedel, C. & Petersen, O. B. (2025). Whole Genome Sequencing in Prenatal Diagnostics: The Danish Approach to Guideline Formation and Implementation Within Public Healthcare. Prenatal Diagnosis. Advance online publication. https://doi.org/10.1002/pd.6780

Kjaergaard, A. D., Vaag, A. A., Jensen, V. H., Olsen, M. H., Højlund, K., Vestergaard, P., Hansen, T., Thomsen, R. W. & Jessen, N. (2025). YKL-40 and risk of incident cancer in early type 2 diabetes: a Danish cohort study. British Journal of Cancer, Artikel 15029. Advance online publication. https://doi.org/10.1038/s41416-025-02996-5

Kjaergaard, A. D., Vaag, A., Jensen, V. H., Olsen, M. H., Højlund, K., Vestergaard, P., Hansen, T., Thomsen, R. W. & Jessen, N. (2025). YKL-40, cardiovascular events, and mortality in individuals recently diagnosed with type 2 diabetes: A Danish cohort study. Diabetes Research and Clinical Practice, 219, Artikel 111970. https://doi.org/10.1016/j.diabres.2024.111970